BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22664043)

  • 21. T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells.
    Abrahamsen IW; Kjellevoll S; Greve-Isdahl M; Mensali N; Wälchli S; Kumari S; Loland BF; Egeland T; Kolstad A; Olweus J
    Int J Cancer; 2012 Apr; 130(8):1821-32. PubMed ID: 21630262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
    Al-Shieban S; Byrne E; Trivedi P; Morilla R; Matutes E; Naresh KN
    Br J Haematol; 2011 Aug; 154(4):466-70. PubMed ID: 21722099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia.
    Craddock KJ; Chen Y; Brandwein JM; Chang H
    Leuk Res; 2013 Jul; 37(7):759-64. PubMed ID: 23643324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].
    Ma J; Sun H; Chen SM; Liu LX; Chen SQ; Liu YF; Xie XS; Meng XL; Deng M; Zhang QT; Li T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):477-81. PubMed ID: 20416193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].
    Xu H; Wei X; Yin Q; Wang P; Mi R; Ai H; Wang X; Li Y; Zhu X; Zhang Y; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):4-9. PubMed ID: 25641137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
    Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
    Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.
    Mannelli F; Gianfaldoni G; Intermesoli T; Cattaneo C; Borlenghi E; Cortelazzo S; Cavattoni I; Pogliani EM; Fumagalli M; Angelucci E; Romani C; Ciceri F; Corti C; Scattolin A; Cortelezzi A; Mattei D; Audisio E; Spinelli O; Oldani E; Bosi A; Rambaldi A; Bassan R
    Haematologica; 2012 Apr; 97(4):568-71. PubMed ID: 22058217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country.
    Patkar N; Alex AA; B B; Ahmed R; Abraham A; George B; Vishwabandya A; Srivastava A; Mathews V
    Cytometry B Clin Cytom; 2012 Jul; 82(4):252-8. PubMed ID: 22467604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of B-Cell Acute Lymphoblastic Leukemia in Brazilian Children: Immunophenotypical, Hematological, and Clinical Evaluation.
    Cézar RS; Cerqueira BA; da Paz Sde S; Barbosa CG; de Moura Neto JP; Barreto JH; Goncalves Mde S
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):423-8. PubMed ID: 26056790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-tumour bone marrow lymphocytes correlate with improved overall survival in childhood acute lymphoblastic leukaemia.
    Edwin C; Dean J; Bonnett L; Phillips K; Keenan R
    Pediatr Blood Cancer; 2016 Oct; 63(10):1848-51. PubMed ID: 27348401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
    Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
    Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia.
    Cheng Y; Luo Z; Yang S; Jia M; Zhao H; Xu W; Tang Y
    Leuk Res; 2015 Feb; 39(2):144-50. PubMed ID: 25542697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relevance of CD20 in adult B-cell precursor acute lymphoblastic leukemia.
    Chang H; Jiang A; Brandwein J
    Haematologica; 2010 Jun; 95(6):1040-2; author reply 1042. PubMed ID: 20107157
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical value of minimal residual disease detection by flow cytometry in childhood B-cell acute lymphoblastic leukemia].
    Chang L; Zhang G; Shi H; Ye L; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1245-9. PubMed ID: 25523574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The age incidence of childhood B-cell precursor acute lymphoblastic leukemia in Mexico City.
    Bernaldez-Rios R; Ortega-Alvarez MC; Perez-Saldivar ML; Alatoma-Medina NE; Del Campo-Martinez Mde L; Rodriguez-Zepeda Mdel C; Montero-Ponce I; Franco-Ornelas S; Fernandez-Castillo G; Nuñez-Villegas NN; Taboada-Flores MA; Flores-Lujano J; Argüelles-Sanchez ME; Juarez-Ocaña S; Fajardo-Gutierrez A; Mejia-Arangure JM
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):199-203. PubMed ID: 18376281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.
    Cruz-Rodriguez N; Combita AL; Enciso LJ; Raney LF; Pinzon PL; Lozano OC; Campos AM; Peñaloza N; Solano J; Herrera MV; Zabaleta J; Quijano S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):37. PubMed ID: 28245840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.